WIINBERG ULF — SEC insider filings
SEC reporting owner CIK 1187314. 44 insider filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 44 filings on record, filed 2020-10-01 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 45,000 shares, $46,646 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: purchase of 16,661 shares @ $1.39 ($23,209) in MiNK Therapeutics, Inc., filed 2022-07-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | Director | 21 | 2 legs · 20,000 sh · $27,646 | — | 21 |
| AGENUS INC (AGEN) | Director | 23 | 1 leg · 25,000 sh · $19,000 | — | 23 |
Insider filings — WIINBERG ULF
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,279 @ $10.95 | EDGAR |
| 2026-06-02 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,285 @ $10.90 · Grant/award (A): 1,131 @ $12.38 | EDGAR |
| 2026-01-06 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 5,395 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,263 @ $11.09 | EDGAR |
| 2025-09-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 3,225 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,011 @ $13.86 | EDGAR |
| 2025-06-04 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,953 @ $7.17 | EDGAR |
| 2025-03-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,593 @ $8.79 | EDGAR |
| 2024-12-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 20,476 @ $0.73 | EDGAR |
| 2024-10-03 | 4 | AGENUS INC (AGEN) | Grant/award (A): 3,423.48 (derivative) | EDGAR |
| 2024-09-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 18,295 @ $0.82 | EDGAR |
| 2024-07-01 | 4 | AGENUS INC (AGEN) | Grant/award (A): 2,121.12 (derivative) | EDGAR |
| 2024-06-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 15,077 @ $0.99 | EDGAR |
| 2024-04-22 | 4 | AGENUS INC (AGEN) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | AGENUS INC (AGEN) | Grant/award (A): 38,635.46 (derivative) | EDGAR |
| 2024-03-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 15,790 @ $0.95 | EDGAR |
| 2024-01-04 | 4 | AGENUS INC (AGEN) | Grant/award (A): 30,956.38 (derivative) | EDGAR |
| 2023-12-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 14,424 @ $1.04 | EDGAR |
| 2023-11-17 | 4 | AGENUS INC (AGEN) | Purchase (P): 25,000 @ $0.76 | EDGAR |
| 2023-10-04 | 4 | AGENUS INC (AGEN) | Grant/award (A): 18,001.06 (derivative) | EDGAR |
| 2023-09-06 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 9,590 @ $1.46 | EDGAR |
| 2023-07-06 | 4 | AGENUS INC (AGEN) | Grant/award (A): 16,018.32 (derivative) | EDGAR |
| 2023-06-16 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 7,955 @ $1.76 | EDGAR |
| 2023-04-03 | 4 | AGENUS INC (AGEN) | Grant/award (A): 11,901.64 (derivative) | EDGAR |
| 2023-03-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 6,699 @ $2.09 | EDGAR |
| 2023-01-09 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | AGENUS INC (AGEN) | Grant/award (A): 9,893.82 (derivative) | EDGAR |
| 2022-12-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 5,364 @ $2.61 | EDGAR |
| 2022-10-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 9,862.29 (derivative) | EDGAR |
| 2022-09-19 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 10,688 @ $2.62 | EDGAR |
| 2022-07-21 | 4 | MiNK Therapeutics, Inc. (INKT) | Purchase (P): 3,339 @ $1.33 · Purchase (P): 16,661 @ $1.39 | EDGAR |
| 2022-07-06 | 4 | AGENUS INC (AGEN) | Grant/award (A): 13,854.98 (derivative) | EDGAR |
| 2022-04-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 9,307.81 (derivative) | EDGAR |
| 2022-03-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-02-08 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-01-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 6,391.99 (derivative) | EDGAR |
| 2021-10-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 4,451.32 (derivative) | EDGAR |
| 2021-07-02 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 6,707.28 (derivative) | EDGAR |
| 2021-06-21 | 4 | AGENUS INC (AGEN) | Option exercise (M): 16,853 | EDGAR |
| 2021-04-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 6,959.90 (derivative) | EDGAR |
| 2021-01-06 | 4 | AGENUS INC (AGEN) | Grant/award (A): 5,896.53 (derivative) | EDGAR |
| 2020-12-21 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2020-10-01 | 4 | AGENUS INC (AGEN) | Grant/award (A): 6,464.58 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187314 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs